Receptor
From Proteopedia
(Difference between revisions)
Line 35: | Line 35: | ||
**[[Lysophosphatidic acid receptor]] | **[[Lysophosphatidic acid receptor]] | ||
**[[User:Harish Srinivas/Sandbox 1|Sphingosine 1-phosphate Receptor]] | **[[User:Harish Srinivas/Sandbox 1|Sphingosine 1-phosphate Receptor]] | ||
+ | **[[Rhodopsin]] | ||
+ | **[[Rhodopsin Structure and Function]] | ||
+ | **[[5-hydroxytryptamine receptor|Serotonin receptors, main page]] | ||
+ | **[[5-hydroxytryptamine receptor 3D structures|3D structures of Serotonin receptors]] | ||
+ | **[[Adrenergic receptor|Adrenergic receptors in general]] | ||
+ | **[[UMass Chem 423 Student Projects 2011-1#Beta-1 Adrenergic GPCR|Beta-1 Adrenergic receptor]] | ||
+ | **Dobutamine, see [[UMass Chem 423 Student Projects 2011-1#Beta-1 Adrenergic GPCR|Beta-1 Adrenergic receptor]], [[2y00]], [[2y01]], [[6h7l]]. | ||
+ | **Isoprenaline, see [[UMass Chem 423 Student Projects 2011-1#Beta-1 Adrenergic GPCR|Beta-1 Adrenergic receptor]], [[2y03]]. | ||
+ | **The human β2 adrenergic receptor bound to a G-protein ([[3sn6]]) is featured in a scene above, and additional structures are on the [[Adrenergic receptor|Adrenergic receptor page]]. | ||
+ | **[[Beta-2 Adrenergic Receptor|Article Beta-2 Adrenergic Receptor by Wayne Decatur, David Canner, Dotan Shaniv, Joel L. Sussman, Michal Harel]] | ||
+ | **[[Beta-2 adrenergic receptor|Article Beta-2 adrenergic receptor by Joel L. Sussman, Tala Curry, Michal Harel, Jaime Prilusky]] | ||
+ | **[[Group:SMART:A Physical Model of the beta-Adrenergic Receptor]] | ||
+ | **G<sub>s</sub>: adenylate cyclase activated, cAMP up. For G<sub>s</sub> see [[Beta2 adrenergic receptor-Gs protein complex updated]] | ||
==Kinase-linked, enzyme-linked and related receptors== | ==Kinase-linked, enzyme-linked and related receptors== |
Revision as of 13:52, 8 April 2021
|
References
- ↑ De Rienzo F, Moura Barbosa AJ, Perez MA, Fernandes PA, Ramos MJ, Menziani MC. The extracellular subunit interface of the 5-HT(3) receptors: a computational alanine scanning mutagenesis study. J Biomol Struct Dyn. 2012 Jul;30(3):280-98. Epub 2012 Jun 12. PMID:22694192 doi:10.1080/07391102.2012.680029
- ↑ Segaliny AI, Tellez-Gabriel M, Heymann MF, Heymann D. Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers. J Bone Oncol. 2015 Jan 23;4(1):1-12. doi: 10.1016/j.jbo.2015.01.001. eCollection , 2015 Mar. PMID:26579483 doi:http://dx.doi.org/10.1016/j.jbo.2015.01.001